Global Liver Institute

Liver Health is Public Health

GLOBAL LIVER INSTITUTE

Liver Health is Public Health
Icon Overview Whitebg1

Liver Health is Public Health Overview

Resources White Icon

Resources

Call To Action White Icon

Media Coverage

LHPH Logo

Liver conditions are misunderstood, mischaracterized, and stigmatized, resulting in under- diagnosis, under-treatment, and unnecessarily poor outcomes around the globe.

Liver Disease Icon

1.5 Billion

people around the world are living with liver disease9

Liver Disease

2 Million

deaths per year are caused by liver conditions globally, and this number is rising1

Liver Disease Icon2

2 Billion

adults worldwide have obesity,10 and 400 million have diabetes11 – both of which are risks for NAFLD/NASH and HCC

About Liver Health is Public Health

In response to the need, the Liver Health is Public Health initiative will elevate liver health to its rightful place on the global public health agenda. It will educate the public about liver health and disease prevention and will pave the way for best practices that account for differences in:

  • 8Stage of disease
  • 8Patient preferences
  • 8Values
  • 8Culture
  • 8Language
  • 8Geography
  • 8Socioeconomic environment

Program Goals

Health Data

To assess and identify, with expertise from all parts of liver health, evidence from existing sources and add to this evidence with patient-generated health data.

Prevent Liver Disease Steap

To educate the general public, patients, providers, payers, policymakers, and the media about the importance of liver health, how to prevent liver disease, steps to take after diagnosis, and more.

Advance Policies Icon

To advance policies that best support liver health by removing barriers to access and to innovation by training a cohort of liver health advocates.

Endorsed by:

For more information or to join the Liver Health is Public Health initiative, please email gdonnini@globalliver.org. We welcome partners and endorsers from the breadth of public health and health care.

This initiative is made possible in the United States thanks to the support of Salix Pharmaceuticals and, globally, thanks to the support of Sanofi.

GAL NPR 0213 Salix Pharma Logo 4C (3)
Sanofi